BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15700304)

  • 21. Expression of human herpesvirus-8 oncogene and cytokine homologues in an HIV-seronegative patient with multicentric Castleman's disease and primary effusion lymphoma.
    Teruya-Feldstein J; Zauber P; Setsuda JE; Berman EL; Sorbara L; Raffeld M; Tosato G; Jaffe ES
    Lab Invest; 1998 Dec; 78(12):1637-42. PubMed ID: 9881964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells.
    Wies E; Mori Y; Hahn A; Kremmer E; Stürzl M; Fleckenstein B; Neipel F
    Blood; 2008 Jan; 111(1):320-7. PubMed ID: 17890449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human herpesvirus 8 (HHV-8)-associated peritoneal primary effusion lymphoma (PEL) in two HIV-negative elderly patients.
    Boulanger E; Hermine O; Fermand JP; Radford-Weiss I; Brousse N; Meignin V; Gessain A
    Am J Hematol; 2004 May; 76(1):88-91. PubMed ID: 15114607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A clinical, molecular and cytogenetic study of 12 cases of human herpesvirus 8 associated primary effusion lymphoma in HIV-infected patients.
    Boulanger E; Agbalika F; Maarek O; Daniel MT; Grollet L; Molina JM; Sigaux F; Oksenhendler E
    Hematol J; 2001; 2(3):172-9. PubMed ID: 11920242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma.
    Deloose ST; Smit LA; Pals FT; Kersten MJ; van Noesel CJ; Pals ST
    Leukemia; 2005 May; 19(5):851-5. PubMed ID: 15744337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human herpesvirus 8 in primary effusion lymphoma in an HIV-seronegative male. A case report.
    Munichor M; Cohen H; Sarid R; Manov I; Iancu TC
    Acta Cytol; 2004; 48(3):425-30. PubMed ID: 15192964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of HHV-8/KSHV infected primary effusion lymphomas in NOD/SCID mice by azidothymidine and interferon-alpha.
    Wu W; Rochford R; Toomey L; Harrington W; Feuer G
    Leuk Res; 2005 May; 29(5):545-55. PubMed ID: 15755507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct cellular origins of primary effusion lymphoma with and without EBV infection.
    Hamoudi R; Diss TC; Oksenhendler E; Pan L; Carbone A; Ascoli V; Boshoff C; Isaacson P; Du MQ
    Leuk Res; 2004 Apr; 28(4):333-8. PubMed ID: 15109530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kaposi sarcoma-associated herpesvirus in non-Hodgkin lymphoma and reactive lymphadenopathy in Uganda.
    Engels EA; Mbulaiteye SM; Othieno E; Gomez M; Mathew S; Cesarman E; Knowles DM; Chadburn A
    Hum Pathol; 2007 Feb; 38(2):308-14. PubMed ID: 17097130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other Kaposi sarcoma herpesvirus-associated disorders.
    Ramaswami R; Lurain K; Marshall VA; Rupert A; Labo N; Cornejo-Castro E; Miley W; Wang HW; Widell A; Lindsley M; Yuan C; Stetler-Stevenson M; Filie AC; Whitby D; Ziegelbauer JM; Uldrick TS; Yarchoan R
    AIDS; 2021 Jan; 35(1):53-62. PubMed ID: 33273183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotypic and clinicopathological characterization of Kaposi's sarcoma-associated herpesvirus infection in Japan.
    Kanno T; Sato Y; Nakamura T; Sakamoto K; Sata T; Katano H
    J Med Virol; 2010 Mar; 82(3):400-6. PubMed ID: 20087946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virology, pathogenetic mechanisms, and associated diseases of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8).
    Sarid R; Klepfish A; Schattner A
    Mayo Clin Proc; 2002 Sep; 77(9):941-9. PubMed ID: 12233927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD).
    Chadburn A; Hyjek EM; Tam W; Liu Y; Rengifo T; Cesarman E; Knowles DM
    Histopathology; 2008 Nov; 53(5):513-24. PubMed ID: 18983461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated disease.
    Marcelin AG; Motol J; Guihot A; Caumes E; Viard JP; Dussaix E; Cadranel J; Frances C; Carcelain G; Calvez V; Dupin N
    J Infect Dis; 2007 Oct; 196(8):1163-6. PubMed ID: 17955434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary effusion lymphoma containing human herpesvirus 8 DNA in two AIDS patients with Kaposi's sarcoma.
    Ascoli V; Mastroianni CM; Galati V; Sirianni MC; Fruscalzo A; Pistilli A; Lo Coco F
    Haematologica; 1998 Jan; 83(1):8-12. PubMed ID: 9542317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative analysis of Kaposi sarcoma-associated herpesvirus (KSHV) in KSHV-associated diseases.
    Asahi-Ozaki Y; Sato Y; Kanno T; Sata T; Katano H
    J Infect Dis; 2006 Mar; 193(6):773-82. PubMed ID: 16479510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple viral infections in primary effusion lymphoma: a model of viral cooperation in lymphomagenesis.
    Gloghini A; Volpi CC; Gualeni AV; Dolcetti R; Bongarzone I; De Paoli P; Carbone A
    Expert Rev Hematol; 2017 Jun; 10(6):505-514. PubMed ID: 28468596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant.
    Cannon JS; Ciufo D; Hawkins AL; Griffin CA; Borowitz MJ; Hayward GS; Ambinder RF
    J Virol; 2000 Nov; 74(21):10187-93. PubMed ID: 11024147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HHV-8 infection is specific for cell lines derived from primary effusion (body cavity-based) lymphomas.
    Uphoff CC; Carbone A; Gaidano G; Drexler HG
    Leukemia; 1998 Nov; 12(11):1806-9. PubMed ID: 9823957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression.
    McHugh D; Caduff N; Barros MHM; Rämer PC; Raykova A; Murer A; Landtwing V; Quast I; Styles CT; Spohn M; Fowotade A; Delecluse HJ; Papoudou-Bai A; Lee YM; Kim JM; Middeldorp J; Schulz TF; Cesarman E; Zbinden A; Capaul R; White RE; Allday MJ; Niedobitek G; Blackbourn DJ; Grundhoff A; Münz C
    Cell Host Microbe; 2017 Jul; 22(1):61-73.e7. PubMed ID: 28704654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.